Dolton, Michael J <br/><br/>
Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Nov 2014 
 - 6879-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.03777-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--pharmacology<br/>Anticonvulsants--pharmacology<br/>Antiemetics--pharmacology<br/>Antifungal Agents--pharmacokinetics<br/>Biological Availability<br/>Carbamates--pharmacology<br/>Drug Interactions<br/>Drug Therapy, Combination--adverse effects<br/>Furans<br/>Healthy Volunteers<br/>Humans<br/>Metoclopramide--pharmacology<br/>Nucleic Acid Synthesis Inhibitors--pharmacology<br/>Organophosphates--pharmacology<br/>Phenytoin--pharmacology<br/>Proton Pump Inhibitors--pharmacology<br/>Rifampin--pharmacology<br/>Sulfonamides--pharmacology<br/>Triazoles--adverse effects